Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders

Journal of Neuromuscular Diseases

Volumn 2, Issue 2, 2015, Pages 107-112

  Emilien, Delmont ^a   Hugh, Willison ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b TIMONE HOSPITAL   (France)

Author keywords

Anti ganglioside antibodies; anti MAG antibodies; Autoantibodies; Inflammatory neuropathy

Indexed keywords

AUTOANTIBODY; GALACTOSYLCERAMIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GD3; GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B ANTIBODY; IMMUNOGLOBULIN ANTIBODY; MOESIN; MYELIN ASSOCIATED GLYCOPROTEIN;

ACUTE MOTOR AXONAL NEUROPATHY; ALGORITHM; ATAXIC GAIT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GUILLAIN BARRE SYNDROME; HUMAN; MOTOR NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHY; NONHUMAN; OPHTHALMOPLEGIA; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 85035209505     PISSN: 22143599     EISSN: 22143602     Source Type: Journal    
DOI: 10.3233/JND-150078     Document Type: Review

References (55)

1. Svennerholm L, 1994 Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog Brain Res 101 XI XIV
2. Plomp JJ, Willison HJ, 2009 Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol 587 16 3979 3999
3. Escande-Beillard N, David MJ, Portoukalian J, Pouget J, Azulay JP, Bernard D BJ, 2002 A sensitive flow cytometry method for anti-GM1 antibodies detection. J Neuroimmunol 125 163 169
4. Caudie C, Quittard Pinon A, Bouhour F, Vial C, Garnier L, Fabien N, 2013 Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies. Clin Lab 59 11-12 1277 1287
5. Willison HJ, Veitch J, Swan A V, Baumann N, Comi G, Gregson NA, 1999 Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol 6 1 71 77
6. Delmont E, Halstead S, Galban-Horcajo F, Yao D, Desnuelle C, Willison H, 2014 Improving the detection of IgM antibodies against glycolipids complexes of GM1 and Galactocerebroside in Multifocal Motor Neuropathy using glycoarray and ELISA assays. J Neuroimmunol 278 159 161
7. Van Schaik IN, Bossuyt PMM, Brand A, Vermeulen M, 1995 Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-Analysis. Neurology 45 8 1570 1577
8. Galban-Horcajo F, Halstead SK, McGonigal R, Willison HJ, 2014 The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders. Curr Opin Chem Biol 18 78 86
9. Lim JP, Devaux J, Yuki N, 2014 Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Autoimmun Rev 13 10 1070 1078
10. Wakerley BR, Uncini A, Yuki N, 2014 Guillain-Barré and Miller Fisher syndromes-new diagnostic classification. Nat Rev Neurol 10 9 537 544
11. Yuki N, Uncini A, 2014 Acute and chronic ataxic neuropathies with disialosyl antibodies: A continuous clinical spectrum and a common pathophysiological mechanism. Muscle Nerve 49 5 629 635
12. Willison HJ, Yuki N, 2002 Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 2591 2625
13. Guimarães-Costa R, Bombelli F, Léger J-M, 2013 Multifocal motor neuropathy. Curr Opin Neurol 26 5 503 509
14. Cats EA, Jacobs BC, Yuki N, Tio-Gillen AP, Piepers S, Franssen H, 2010 Multifocal motor neuropathy: Association of anti-GM1 IgM antibodies with clinical features. Neurology 75 22 1961 1967
15. Willison HJ, O'Leary CP, Veitch J, Blumhardt LD, Busby M, Donaghy M, 2001 The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124 1968 1977
16. Attarian S, Boucraut J, Hubert AM, Uzenot D, Delmont E, Verschueren A, 2009 Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: Response to IVIg therapy. J Neurol Neurosurg Psychiatry 81 1 61 64
17. Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, 2004 Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol 56 4 567 571
18. Rinaldi S, Brennan KM, Kalna G, Walgaard C, van Doorn P, Jacobs BC, 2013 Antibodies to heteromeric glycolipid complexes in guillain-barré syndrome. PLoS One 8 12 e82337
19. Shahrizaila N, Kokubun N, Sawai S, Umapathi T, Chan Y-C, Kuwabara S, 2014 Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes. Neurology 83 2 118 124
20. Nobile-Orazio E, Giannotta C, Musset L, Messina P, Léger J-M, 2014 Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 85 7 754 758
21. Pestronk A, Choksi R, Blume G, Lopate G, 1997 Multifocal motor neuropathy: Serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GMl alone. Neurology 48 4 1104 1106
22. Galban-Horcajo F, Fitzpatrick AM, Hutton AJ, Dunn SM, Kalna G, Brennan KM, 2013 Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy. Eur J Neurol 20 1 62 70
23. Rinaldi S, Brennan KM, Willison HJ, 2010 Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. Prog Lipid Res 49 1 87 95
24. Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC, 1995 Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 38 2 218 224
25. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, 2004 Carbohydrate mimicry between human gangliosideGM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A 101 31 11404 11409
26. Jacobs BC, O'Hanlon GM, Breedland EG, Veitch J, van Doorn PA, Willison HJ, 1997 Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides. J Neuroimmunol 80 1-2 23 30
27. Caporale CM, Capasso M, Luciani M, Prencipe V, Creati B, Gandolfi P, 2006 Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome. J Neuroimmunol 174 1-2 12 20
28. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I, 1996 Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39 4 424 431
29. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, 2001 Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49 6 712 720
30. Fewou SN, Plomp JJ, Willison HJ, 2014 The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies. J Anat 224 1 36 44
31. Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP, 1992 Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 31 4 385 390
32. Uncini A, Susuki K, Yuki N, 2013 Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophysiol 124 10 1928 1934
33. Miller JAL, Spyropoulos A, Jaros E, Galban-horcajo F, Infirmary RV, Hospitals N, 2014 Anti-GQ1b ganglioside positive Miller Fisher syndrome - evidence of paranodal pathology on nerve biopsy. J Neuromuscul Dis 1 191 195
34. Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, 1994 Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36 3 416 424
35. Launay M, Delmont E, Benaím C, Sacconi S, Butori C, Desnuelle C, 2009 Les polyneuropathies avec IgM monoclonale anti-MAG: étude descriptive clinique, biologique, électrophysiologique et anatomopathologique d'une cohorte de 13 patients. Rev Neurol (Paris) 165 12 1071 1079
36. Joint Task Force of the EFNS and the PNS 2010 European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Societ. J Peripher Nerv Syst 185 195
37. Attarian S, Azulay JP, Boucraut J, Escande N, Pouget J, 2001 Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies. Clin Neurophysiol 112 3 457 463
38. Kuijf ML, Eurelings M, Tio-Gillen a P, van Doorn P a, van den Berg LH, Hooijkaas H, 2009 Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 73 9 688 695
39. Caudie C, Kaygisiz F, Jaquet P, Petiot P, Gonnaud P-M, Antoine JC, 2006 [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG]. Ann Biol Clin (Paris) 64 4 353 359
40. Hamada Y, Hirano M, Kuwahara M, Samukawa M, Takada K, Morise J, 2014 Binding specificity of anti-HNK-1 IgMM-protein in anti-MAG neuropathy: Possible clinical relevance. Neurosci Res 1 6
41. Planche V, Arnaud L, Viala K, Hospital Marie Anne, Miraya M, Leger Jean-Marc, Neil J, Leblond V, Musset L, 2014 Heavy/Light Chain Ratio as a Biomarker for Monitoring Patients with IgM Monoclonal Gammopathy and Anti-MAG Neuropathy. J Hematol Thrombo Dis 2 3 142
42. Lunn MPT, Nobile-Orazio E, 2012 Immunotherapy for IgM anti-myelin-Associated glycoprotein paraprotein-Associated peripheral neuropathies. Cochrane database Syst Rev 5 CD002827
43. Léger J-M, Viala K, Nicolas G, Créange A, Vallat J-M, Pouget J, 2013 Placebo-controlled trial of rituximab in IgM anti-myelin-Associated glycoprotein neuropathy. Neurology 80 2217 2225
44. Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, 2009 Placebo-controlled trial of rituximab in IgM anti-myelin-Associated glycoprotein antibody demyelinating neuropathy. Ann Neurol 65 3 286 293
45. Benedetti L, Briani C, Grandis M, Vigo T, Gobbi M, Ghiglione E, 2007 Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. J Peripher Nerv Syst 12 2 102 107
46. Giannotta C, Di Pietro D, Gallia F, Nobile-Orazio E, 2015 Anti-sulfatide IgM antibodies in peripheral neuropathy: To test or not to test? Eur J Neurol 10.1111/ene.12658. [Epub ahead of print]
47. Yuki N, Tagawa Y, Handa S, 1996 Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 70 1 1 6
48. Notturno F, Di Febo T, Yuki N, Fernandez Rodriguez BM, Corti D, Nobile-Orazio E, 2014 Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy. J Neuroimmunol 276 1-2 207 212
49. Querol L, Nogales-Gadea G, Rojas-Garcia R, Martinez-Hernandez E, Diaz-Manera J, Suárez-Calvet X, 2013 Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 73 3 370 380
50. Ng JKM, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, 2012 Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79 23 2241 2248
51. Kuwahara M, Suzuki H, Samukawa M, Hamada Y, Takada K, Kusunoki S, 2013 Clinical features of CIDP with LM1-Associated antibodies. J Neurol Neurosurg Psychiatry 84 5 573 575
52. Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A, Sedano MJ, Gallardo E, Berciano J, Blesa R, Dalmau J, Illa I, 2014 Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82 10 879 886
53. Sawai S, Satoh M, Mori M, Misawa S, Sogawa K, Kazami T, 2014 Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome. Neurology 83 2 113 117
54. Willison H, Scherer SS, 2014 Ranvier revisited: Novel nodal antigens stimulate interest in GBS pathogenesis. Neurology 83 2 106 108
55. Desmazieres A, Zonta B, Zhang A, Wu L-MN, Sherman DL, Brophy PJ, 2014 Differential stability of PNS and CNS nodal complexes when neuronal neurofascin is lost. J Neurosci 34 15 5083 5088